Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

156 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Overview of cellular immunotherapy for patients with glioblastoma.
Vauleon E, Avril T, Collet B, Mosser J, Quillien V. Vauleon E, et al. Among authors: collet b. Clin Dev Immunol. 2010;2010:689171. doi: 10.1155/2010/689171. Epub 2010 Oct 4. Clin Dev Immunol. 2010. PMID: 20953324 Free PMC article. Review.
Injection by various routes of melanoma antigen-associated macrophages: biodistribution and clinical effects.
Lesimple T, Moisan A, Carsin A, Ollivier I, Mousseau M, Meunier B, Leberre C, Collet B, Quillien V, Drenou B, Lefeuvre-Plesse C, Chevrant-Breton J, Toujas L. Lesimple T, et al. Among authors: collet b. Cancer Immunol Immunother. 2003 Jul;52(7):438-44. doi: 10.1007/s00262-003-0390-y. Epub 2003 Apr 11. Cancer Immunol Immunother. 2003. PMID: 12690521 Clinical Trial.
Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients.
Lesimple T, Neidhard EM, Vignard V, Lefeuvre C, Adamski H, Labarrière N, Carsin A, Monnier D, Collet B, Clapisson G, Birebent B, Philip I, Toujas L, Chokri M, Quillien V. Lesimple T, et al. Among authors: collet b. Clin Cancer Res. 2006 Dec 15;12(24):7380-8. doi: 10.1158/1078-0432.CCR-06-1879. Clin Cancer Res. 2006. PMID: 17189411 Clinical Trial.
Proteomic analysis underlines the usefulness of both primary adherent and stem-like cell lines for studying proteins involved in human glioblastoma.
Collet B, Avril T, Aubry M, Hamlat A, Le Reste PJ, Chiforeanu D, Vauleon E, Mosser J, Quillien V. Collet B, et al. J Proteomics. 2014 Oct 14;110:7-19. doi: 10.1016/j.jprot.2014.07.022. Epub 2014 Aug 1. J Proteomics. 2014. PMID: 25088051
Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach.
Collet B, Guitton N, Saïkali S, Avril T, Pineau C, Hamlat A, Mosser J, Quillien V. Collet B, et al. Proteome Sci. 2011 Apr 6;9(1):16. doi: 10.1186/1477-5956-9-16. Proteome Sci. 2011. PMID: 21470419 Free PMC article.
Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy.
Saikali S, Avril T, Collet B, Hamlat A, Bansard JY, Drenou B, Guegan Y, Quillien V. Saikali S, et al. Among authors: collet b. J Neurooncol. 2007 Jan;81(2):139-48. doi: 10.1007/s11060-006-9220-3. Epub 2006 Sep 27. J Neurooncol. 2007. PMID: 17004103
Expression of MAGE genes in esophageal squamous-cell carcinoma.
Quillien V, Raoul JL, Heresbach D, Collet B, Toujas L, Brasseur F. Quillien V, et al. Among authors: collet b. Anticancer Res. 1997 Jan-Feb;17(1A):387-91. Anticancer Res. 1997. PMID: 9066682
Characterization of the antigen identified by Po66. A monoclonal antibody raised against a lung squamous cell carcinoma.
Martin A, Pellen P, Guitton C, Youinou P, Collet B, Desrues B, Bourel D, Dazord L, Toujas L. Martin A, et al. Among authors: collet b. Cancer Immunol Immunother. 1989;29(2):118-24. doi: 10.1007/BF00199286. Cancer Immunol Immunother. 1989. PMID: 2541906
Scintigraphic detection in mice of inflammatory lesions and tumours by an indium-labelled monoclonal antibody directed against Mac-1 antigen.
Collet B, Pellen P, Martin A, Moisan A, Bourel D, Toujas L. Collet B, et al. Cancer Immunol Immunother. 1988;26(3):237-42. doi: 10.1007/BF00199935. Cancer Immunol Immunother. 1988. PMID: 3289745
Fate of mouse macrophages radiolabelled with PKH-95 and injected intravenously.
Audran R, Collet B, Moisan A, Toujas L. Audran R, et al. Among authors: collet b. Nucl Med Biol. 1995 Aug;22(6):817-21. doi: 10.1016/0969-8051(95)00013-n. Nucl Med Biol. 1995. PMID: 8535344
156 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page